IQVIA Holdings Inc. announced the pricing of a $2 billion offering of senior notes due in March 2034, bearing an interest rate of 6.375% per annum with semi-annual payments. The subsidiary intends to use the gross proceeds to fully redeem its existing Senior 5.000% Notes due 2026, repay a portion of outstanding indebtedness under its revolving credit facility, and cover related fees and expenses. The transaction is expected to close on or about September 23, 2026, subject to customary conditions. IQVIA operates in the life sciences and healthcare industries as a global provider of clinical research services, commercial insights, and healthcare intelligence.
